Found: 86
Select item for more details and to access through your institution.
Natural cubic splines for the analysis of Alzheimer's clinical trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 508, doi. 10.1002/pst.2285
- By:
- Publication type:
- Article
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2427073, doi. 10.1001/jamanetworkopen.2024.27073
- By:
- Publication type:
- Article
Can Consumers Trust Web-Based Information About Celiac Disease? Accuracy, Comprehensiveness, Transparency, and Readability of Information on the Internet.
- Published in:
- Journal of Medical Internet Research, 2012, v. 14, n. 2, p. 25, doi. 10.2196/ijmr.2010
- By:
- Publication type:
- Article
Duration of Smoking Abstinence and Suicide-Related Outcomes.
- Published in:
- Nicotine & Tobacco Research, 2011, v. 13, n. 10, p. 887, doi. 10.1093/ntr/ntr089
- By:
- Publication type:
- Article
Tau positron emission tomography in preclinical Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 700, doi. 10.1093/brain/awac299
- By:
- Publication type:
- Article
Disease progression models for dominantly-inherited Alzheimer's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 5, p. 776, doi. 10.1002/acn3.51048
- By:
- Publication type:
- Article
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 5, p. 534, doi. 10.1002/acn3.192
- By:
- Publication type:
- Article
Power and Sample Size for Longitudinal Models in R - The longpower Package and Shiny App.
- Published in:
- R Journal, 2022, v. 14, n. 1, p. 264, doi. 10.32614/rj-2022-022
- By:
- Publication type:
- Article
Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
- Published in:
- 2017
- By:
- Publication type:
- letter
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative.
- Published in:
- Neurodegenerative Diseases, 2018, v. 18, n. 4, p. 173, doi. 10.1159/000488780
- By:
- Publication type:
- Article
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12135
- By:
- Publication type:
- Article
The relative efficiency of time‐to‐progression and continuous measures of cognition in presymptomatic Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 308, doi. 10.1016/j.trci.2019.04.004
- By:
- Publication type:
- Article
Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 2, p. 1, doi. 10.1002/dad2.12431
- By:
- Publication type:
- Article
Infection Rates of Electrical Leads Used for Percutaneous Neurostimulation of the Peripheral Nervous System.
- Published in:
- Pain Practice, 2017, v. 17, n. 6, p. 753, doi. 10.1111/papr.12523
- By:
- Publication type:
- Article
Alternatives to MMRM for preclinical Alzheimer's clinical trials: Clinical trial design and implementation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044915
- By:
- Publication type:
- Article
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer's disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044511
- By:
- Publication type:
- Article
The anti‐amyloid treatment in asymptomatic Alzheimer's disease (A4) study: Report of screening and recruitment characteristics of the Melbourne composite site: Human/Prevention (clinical).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042786
- By:
- Publication type:
- Article
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 797, doi. 10.1002/alz.12058
- By:
- Publication type:
- Article
DT‐02‐03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1489, doi. 10.1016/j.jalz.2019.08.012
- By:
- Publication type:
- Article
P4‐245: THE ASSOCIATION BETWEEN INSTRUMENTAL ACTIVITIES OF DAILY LIVING AND CORTICAL AMYLOID IN COGNITIVELY NORMAL OLDER ADULTS SCREENING FOR THE A4 STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1372, doi. 10.1016/j.jalz.2019.06.3908
- By:
- Publication type:
- Article
P4‐024: THE RELATIVE EFFICIENCY OF TIME‐TO‐PROGRESSION AND CONTINUOUS MEASURES OF COGNITION IN PRECLINICAL ALZHEIMER'S.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1283, doi. 10.1016/j.jalz.2019.06.3683
- By:
- Publication type:
- Article
FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P873, doi. 10.1016/j.jalz.2019.06.4621
- By:
- Publication type:
- Article
P1‐286: GERIATRIC DEPRESSION SCALE (GDS) ITEM‐LEVEL ANALYSIS BY AMYLOID PET AND COGNITION: FINDINGS FROM THE ANTI‐AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMER'S DISEASE (A4) STUDY SCREENING DATA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P352, doi. 10.1016/j.jalz.2019.06.841
- By:
- Publication type:
- Article
O1‐09‐01: ESTIMATING YEARS FROM CLINICAL SYMPTOM ONSET FOR SPORADIC ALZHEIMER DISEASE: HOW FAR ARE WE?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P216, doi. 10.1016/j.jalz.2019.06.4565
- By:
- Publication type:
- Article
F1‐01‐02: ITEM‐LEVEL COMPARISON OF PARTICIPANT AND STUDY PARTNER REPORT ON THE COGNITIVE FUNCTION INDEX BY AMYLOID PET FROM THE A4 STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P175, doi. 10.1016/j.jalz.2019.06.4370
- By:
- Publication type:
- Article
A randomized clinical trial to evaluate home‐based assessment of people over 75 years old.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 5, p. 615, doi. 10.1016/j.jalz.2019.01.007
- By:
- Publication type:
- Article
Participant satisfaction with dementia prevention research: Results from Home‐Based Assessment trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 11, p. 1397, doi. 10.1016/j.jalz.2018.05.016
- By:
- Publication type:
- Article
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 9, p. 1193, doi. 10.1016/j.jalz.2018.04.010
- By:
- Publication type:
- Article
Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 8, p. 1077, doi. 10.1016/j.jalz.2018.03.009
- By:
- Publication type:
- Article
P4‐341: THE COMPUTERIZED COGNITIVE COMPOSITE (C3) AND AMYLOID STATUS AMONG NORMAL OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1597, doi. 10.1016/j.jalz.2018.07.164
- By:
- Publication type:
- Article
P4‐321: TAU PET IN A4: PRELIMINARY REPORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1583, doi. 10.1016/j.jalz.2018.07.144
- By:
- Publication type:
- Article
P4‐014: ESTIMAND IN EARLY ALZHEIMER'S DISEASE: PROGRESS UPDATE FROM THE INTERNATIONAL ALZHEIMER'S DISEASE SCIENTIFIC WORKING GROUP (AD SWG) SUBSTREAM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1437, doi. 10.1016/j.jalz.2018.06.2416
- By:
- Publication type:
- Article
O1‐02‐05: PREDICTING AMYLOID BURDEN IN SCREENING FOR PRECLINICAL AD PREVENTION TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P217, doi. 10.1016/j.jalz.2018.06.2340
- By:
- Publication type:
- Article
O1‐02‐02: THE ANTI‐AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMER'S DISEASE (A4) STUDY: REPORT OF SCREENING DATA RESULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P215, doi. 10.1016/j.jalz.2018.06.2337
- By:
- Publication type:
- Article
O1‐02‐01: IMPACT OF DISCLOSING AMYLOID IMAGING RESULTS TO COGNITIVELY NORMAL RESEARCH PARTICIPANTS: THE A4 EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P215, doi. 10.1016/j.jalz.2018.06.2336
- By:
- Publication type:
- Article
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, n. 9, p. 1004, doi. 10.1016/j.jalz.2017.01.018
- By:
- Publication type:
- Article
CROSS-VALIDATION OF OPTIMIZED COMPOSITES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P830, doi. 10.1016/j.jalz.2016.06.1691
- By:
- Publication type:
- Article
The transitional association between β-amyloid pathology and regional brain atrophy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 10, p. 1171, doi. 10.1016/j.jalz.2014.11.002
- By:
- Publication type:
- Article
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 9, p. 1069, doi. 10.1016/j.jalz.2014.07.156
- By:
- Publication type:
- Article
Inclusion criteria and cognitive responses to optimize trials in Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P829, doi. 10.1016/j.jalz.2015.06.1841
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 823, doi. 10.1016/j.jalz.2015.05.004
- By:
- Publication type:
- Article
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 865, doi. 10.1016/j.jalz.2015.04.005
- By:
- Publication type:
- Article
Estimating long-term multivariate progression from short-term data.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 5, p. S400, doi. 10.1016/j.jalz.2013.10.003
- By:
- Publication type:
- Article
Assessing clinical progression for dementia prevention trial: results from the hba trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P138, doi. 10.1016/j.jalz.2014.04.084
- By:
- Publication type:
- Article
Modeling long-term disease progression with covariates.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P203, doi. 10.1016/j.jalz.2014.04.253
- By:
- Publication type:
- Article
Requiring an amyloid-β<sub>1–42</sub> biomarker for prodromal Alzheimer’s disease or mild cognitive impairment does not lead to more efficient clinical trials
- Published in:
- 2011
- By:
- Publication type:
- Letter
Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 3, p. 239, doi. 10.1016/j.jalz.2010.03.006
- By:
- Publication type:
- Article
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.
- Published in:
- Frontiers in Computational Neuroscience, 2015, p. 1, doi. 10.3389/fnbeh.2015.00239
- By:
- Publication type:
- Article